II Calendar No. 351 112th CONGRESS 2d Session S. 2159 IN THE SENATE OF THE UNITED STATES March 6, 2012 Mr. Leahy (for himself, Mr. Grassley, Mrs. Feinstein, Mr. Portman, Mr. Schumer, Ms. Klobuchar, and Mr. Kohl) introduced the following bill; which was read twice and referred to the Committee on the Judiciary March 29, 2012 Reported by Mr. Leahy, with an amendment Strike out all after the enacting clause and insert the part printed in italic A BILL To extend the authorization of the Drug-Free Communities Support Program through fiscal year 2017.

1.

Extension of the Drug-Free Communities Support Program through fiscal year 2017

Section 1024(a) of the National Narcotics Leadership Act of 1988 (21 U.S.C. 1524(a)) is amended by striking paragraph (9) and all that follows and inserting the following: (9)$90,000,000 for fiscal year 2006; (10)$99,000,000 for fiscal year 2007; (11)$109,000,000 for fiscal year 2008; (12)$114,000,000 for fiscal year 2009; (13)$119,000,000 for fiscal year 2010; (14)$124,000,000 for fiscal year 2011; (15)$129,000,000 for fiscal year 2012; (16)$100,000,000 for fiscal year 2013; (17)$100,000,000 for fiscal year 2014; (18)$100,000,000 for fiscal year 2015; (19)$100,000,000 for fiscal year 2016; and (20)$100,000,000 for fiscal year 2017. .

1.

Extension of the Drug-Free Communities Support Program through fiscal year 2017

Section 1024(a) of the National Narcotics Leadership Act of 1988 (21 U.S.C. 1524(a)) is amended by striking paragraph (9) and all that follows and inserting the following: (9)$90,000,000 for fiscal year 2006; (10)$99,000,000 for fiscal year 2007; (11)$109,000,000 for fiscal year 2008; (12)$114,000,000 for fiscal year 2009; (13)$119,000,000 for fiscal year 2010; (14)$124,000,000 for fiscal year 2011; (15)$129,000,000 for fiscal year 2012; (16)$100,000,000 for fiscal year 2013; (17)$100,000,000 for fiscal year 2014; (18)$100,000,000 for fiscal year 2015; (19)$100,000,000 for fiscal year 2016; and (20)$100,000,000 for fiscal year 2017. .

2.

Oversight of other agency administering Drug-Free Communities Support Program

Section 1031 of the National Narcotics Leadership Act of 1988 (21 U.S.C. 1531) is amended— (1)in subsection (b)— (A)in paragraph (2), by striking and at the end; (B)in paragraph (3), by striking the period at the end and inserting ; and; and (C)by adding at the end the following: (4)ensure that— (A)each recipient of an initial grant or a renewal grant meets the grant eligibility criteria under section 1032(a) for each fiscal year; and (B)the meeting of the grant eligibility criteria under section 1032(a) for each fiscal year by each recipient of an initial grant or a renewal grant is fully documented. ; and (2)in subsection (d)— (A)by striking The Director and inserting the following: (1) In general.—The Director; and (B)by adding at the end the following: (2)

Oversight of other agency administering Program

If the Director enters into an agreement under paragraph (1) to delegate authority to the Substance Abuse and Mental Health Services Administration, the Director shall— (A)develop and document an approach to monitoring and overseeing the administration of the Program by the Substance Abuse and Mental Health Services Administration; and (B)fully define in the agreement prepared for each fiscal year between the Director and the Substance Abuse and Mental Health Services Administration the respective roles and responsibilities, with respect to administering the Program, of— (i)the Office of National Drug Control Policy, including the role and responsibilities of the Administrator; and (ii)the Substance Abuse and Mental Health Services Administration. .

3.

National Community Anti-Drug Coalition Institute

Subchapter I of chapter 2 of the National Narcotics Leadership Act of 1988 (21 U.S.C. 1531 et seq.) is amended by adding at the end the following:

1036.

National Community Anti-Drug Coalition Institute

(a)

In general

The Director may, using amounts authorized to be appropriated by subsection (d), make a grant to an eligible organization to provide for the establishment of a National Community Anti-Drug Coalition Institute. (b)

Eligible organizations

An organization eligible for the grant under subsection (a) is any national nonprofit organization that represents, provides technical assistance and training to, and has special expertise and broad, national-level experience in community anti-drug coalitions under section 1032. (c)

Use of grant amount

The organization receiving the grant under subsection (a) shall establish a National Community Anti-Drug Coalition Institute to— (1)provide education, training, and technical assistance for coalition leaders and community teams, with emphasis on the development of coalitions serving economically disadvantaged areas; (2)develop and disseminate evaluation tools, mechanisms, and measures to better assess and document coalition performance measures and outcomes; and (3)bridge the gap between research and practice by translating knowledge from research into practical information. (d)

Authorization of appropriations

There is authorized to be appropriated for purposes of activities under this section, including the grant under subsection (a), $2,000,000 for each of fiscal years 2013 through 2017.

.

March 29, 2012 Reported with an amendment